McNeil implements corrective action plan

By Modern Materials Handling Staff
April 01, 2010 - MMH Editorial

In the wake of a product recall that included more than 50 million units of Tylenol arthritis products, St. Joseph's Aspirin, Motrin and other products, the McNeil Consumer Healthcare unit of Johnson & Johnson reported that it has taken steps to ensure that similar situations do not happen in the future. In a letter to the U.S. Food and Drug Administration, Peter Luther, McNeil president, wrote, “McNeil and Johnson & Johnson management are taking this issue very seriously and are committed to ensuring that McNeil implements all necessary corrective and preventive actions to improve the McNeil quality systems.” The letter also outlined key elements of the corrective action plan that includes enhancements to the quality system, organizational changes, and senior management oversight. For more, go to Modern's Web site, mmh.com/recall.



Subscribe to Modern Materials Handling magazine

Subscribe today. It's FREE!
Find out what the world's most innovative companies are doing to improve productivity in their plants and distribution centers.
Start your FREE subscription today!

Recent Entries

Equipment Leasing and Finance Association’s show year-to-date volume up 8% over same period in 2013.

Made up of nine- to 14-year olds, six teams of eight will face off in a series of

Even more than doubles the number of exhibitors and attendees since 2012.

Parent company's Logistics & Automation Division began servicing North American customers in 1962, 12 years before Murata machinery was established.

Article Topics

Features · Up Front · Packaging · Pallets · All topics

Comments

Post a comment
Commenting is not available in this channel entry.


© Copyright 2013 Peerless Media LLC, a division of EH Publishing, Inc • 111 Speen Street, Ste 200, Framingham, MA 01701 USA